TETRA Technologies, Inc. (TTI) Reaches $3.50 After 8.00% Down Move; Cormorant Asset Management Has Cut Its Neurocrine Biosciences (NBIX) Stake

November 14, 2017 - By Vivian Park

The stock of TETRA Technologies, Inc. (NYSE:TTI) is a huge mover today! The stock decreased 5.28% or $0.19 during the last trading session, reaching $3.5. About 1.36M shares traded or 51.51% up from the average. TETRA Technologies, Inc. (NYSE:TTI) has declined 31.41% since November 14, 2016 and is downtrending. It has underperformed by 48.11% the S&P500.The move comes after 5 months negative chart setup for the $405.61M company. It was reported on Nov, 14 by Barchart.com. We have $3.22 PT which if reached, will make NYSE:TTI worth $32.45M less.

Cormorant Asset Management Llc decreased Neurocrine Biosciences Inc (NBIX) stake by 16.67% reported in 2017Q2 SEC filing. Cormorant Asset Management Llc sold 50,000 shares as Neurocrine Biosciences Inc (NBIX)’s stock rose 19.84%. The Cormorant Asset Management Llc holds 250,000 shares with $11.50M value, down from 300,000 last quarter. Neurocrine Biosciences Inc now has $6.56 billion valuation. The stock rose 0.04% or $0.03 reaching $74.2. About 832,454 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 12.51% since November 14, 2016 and is uptrending. It has underperformed by 4.19% the S&P500.

Analysts await Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to report earnings on February, 13. They expect $-0.03 EPS, up 94.12% or $0.48 from last year’s $-0.51 per share. After $-0.13 actual EPS reported by Neurocrine Biosciences, Inc. for the previous quarter, Wall Street now forecasts -76.92% EPS growth.

Since May 18, 2017, it had 0 insider buys, and 1 sale for $533,900 activity. 10,000 shares were sold by Grigoriadis Dimitri E., worth $533,900 on Tuesday, May 23. $5.63 million worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares were sold by OBrien Christopher Flint. The insider Lippoldt Darin sold $532,700. Another trade for 9,960 shares valued at $534,155 was made by Lloyd-Smith Malcolm on Thursday, May 18.

Among 12 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 37 analyst reports since August 18, 2015 according to SRatingsIntel. As per Thursday, November 2, the company rating was maintained by Barclays Capital. Deutsche Bank maintained the shares of NBIX in report on Thursday, November 2 with “Buy” rating. On Thursday, April 7 the stock rating was initiated by BMO Capital Markets with “Outperform”. Oppenheimer maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Wednesday, July 5 with “Buy” rating. The company was maintained on Thursday, November 2 by Oppenheimer. BMO Capital Markets maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Friday, October 20 with “Buy” rating. As per Tuesday, November 22, the company rating was initiated by Oppenheimer. H.C. Wainwright maintained the shares of NBIX in report on Tuesday, July 11 with “Buy” rating. The rating was reinitiated by Jefferies on Tuesday, August 18 with “Buy”. As per Monday, September 25, the company rating was maintained by Cowen & Co.

Investors sentiment increased to 1.25 in 2017 Q2. Its up 0.22, from 1.03 in 2017Q1. It improved, as 33 investors sold NBIX shares while 59 reduced holdings. 44 funds opened positions while 71 raised stakes. 91.92 million shares or 11.33% more from 82.57 million shares in 2017Q1 were reported. X Communications Lc reported 436 shares stake. Davidson Kempner Capital Management LP stated it has 0.09% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Next Finance Gp accumulated 0% or 100 shares. Susquehanna Group Inc Ltd Liability Partnership has 8,251 shares. Bluecrest Cap Mgmt invested in 0.02% or 12,100 shares. Shanda Asset Mngmt Limited, Virgin Islands – British-based fund reported 10,000 shares. Us Bancorporation De holds 0% or 606 shares. Schroder Investment Group invested in 20,496 shares. 3.58 million are held by Perceptive Advisors Ltd Liability Corporation. holds 0.01% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) or 688,000 shares. 33,705 were reported by Amer Century. Advisory reported 21,768 shares. Tiaa Cref Investment Lc, a New York-based fund reported 329,035 shares. De Burlo Grp owns 0.23% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 22,350 shares. Massachusetts Fincl Services Ma owns 106,546 shares.

TETRA Technologies, Inc. is an oil and gas services company. The company has market cap of $405.61 million. The Firm focuses on completion fluids and associated services and products, water management, production well testing, offshore rig cooling, compression services and equipment, and offshore services, such as decommissioning and diving. It currently has negative earnings. It is composed of five divisions organized into four divisions: Fluids, Production Testing, Compression and Offshore.

Analysts await TETRA Technologies, Inc. (NYSE:TTI) to report earnings on March, 7. They expect $-0.05 EPS, up 68.75% or $0.11 from last year’s $-0.16 per share. After $0.04 actual EPS reported by TETRA Technologies, Inc. for the previous quarter, Wall Street now forecasts -225.00% negative EPS growth.

Among 15 analysts covering Tetra Technologies (NYSE:TTI), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Tetra Technologies has $12 highest and $3.25 lowest target. $6.58’s average target is 88.00% above currents $3.5 stock price. Tetra Technologies had 37 analyst reports since August 10, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, November 8 by Credit Suisse. The firm earned “Hold” rating on Thursday, August 13 by Zacks. The firm earned “Outperform” rating on Tuesday, May 10 by Cowen & Co. RBC Capital Markets maintained it with “Hold” rating and $4.0 target in Thursday, November 9 report. The company was maintained on Friday, November 10 by Loop Capital. As per Tuesday, November 8, the company rating was maintained by RBC Capital Markets. RBC Capital Markets maintained it with “Hold” rating and $3.25 target in Friday, September 1 report. The stock of TETRA Technologies, Inc. (NYSE:TTI) has “Overweight” rating given on Tuesday, November 10 by JP Morgan. J.P. Morgan downgraded the shares of TTI in report on Tuesday, September 12 to “Hold” rating. The stock of TETRA Technologies, Inc. (NYSE:TTI) earned “Neutral” rating by JP Morgan on Tuesday, September 12.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Park




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: